Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLVE II: Epanova vs olive oil in severe hypertriglyceridemia
2013-004682-14Phase 3Completed
- Sponsor
- Omthera Pharmaceuticals
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia (2 arms), sponsored by Omthera Pharmaceuticals. Primary endpoint: Percent change in triglycerides. Started Jan 2014; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on 2013-004682-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004682-14.